Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: worsening dyspnea on exertion major surgical or invasive procedure: minimally invasive mvr(29mm porcine valve) history of present illness: mr. is a 55 year old man with known mitral valve regurgitation and mitral valve prolapse. he has recently had worsening dyspnea on exertion and worsening mitral valve regurgitation by echocardiogram. he is admitted for surgical management. past medical history: hypercholesterolemia detached retina basal cell carcinoma s/p removal of mass from right foot and groin. s/p tonsillectomy/adenoidectomy social history: lives with partner in . works in sales. quit smoking in and drinks moderately on weekends. family history: adopted and does not know biological family history physical exam: vs: hr 60 bp(right) 108/70 bp(left) 110/72 ht 77" wt 245 gen: well developed and well nourished. no acute distress skin: no lesions or rashes heent: perrl, eomi, benign oropharynx neck: supple, no lymphadenopathy lungs: clear heart: rrr, normal s1-s2, iii/vi systolic murmur. abdomen: soft, nontender, nondistended. ext: warm, well perfused. no edema neuro: nonfocal pulses: 2+ throughout. no bruits pertinent results: 06:40am blood wbc-8.6 rbc-3.50* hgb-11.2* hct-32.4* mcv-93 mch-32.1* mchc-34.6 rdw-12.4 plt ct-82* 06:40am blood plt ct-82* 06:40am blood glucose-114* urean-17 creat-1.0 na-138 k-4.3 cl-101 hco3-34* angap-7* 05:36pm blood urean-17 creat-0.8 cl-111* hco3-23 06:40am blood alt-32 ast-44* ld(ldh)-457* alkphos-56 amylase-154* totbili-0.9 03:54am blood glucose-140* lactate-1.0 na-134* k-4.9 cl-105 calhco3-27 07:44am blood glucose-109* na-138 k-3.9 cxr increased bilateral pleural effusion with atelectasis. no pneumothorax. ekg sinus rhythm and occasional ventricular ectopy. prior inferior and posterior myocardial infarction. compared to the previous tracing of ventricular ectopy is no longer recorded and the rate has increased. otherwise, no diagnostic interim change. brief hospital course: mr. was admitted to the medical center on for surgical management of his mitral valve disease. he was worked-up in the usual preoperative manner. he was then taken to the operating room where he underwent a minimally invasive mitral valve replacement utilizing a 29 mm mosaic porcine valve. postoperatively he was taken to the cardiac surgical intensive care unit for monitoring. on postoperative day one, mr. neurologically intact and was extubated. he developed hyperamylase and lipasemia and was thus restricted from oral intake. the general surgery service was consulted and recommended serial labs and exams as he was asymptomatic. clear liquids were ultimately started and advanced as tolerated. on postoperative day three, mr. was transferred to the cardiac surgical step down unit for further recovery. he was gently diuresed towards his preoperative weight. the physical therapy service was consulted for assistance with his postoperative strength and mobility. as mr. was somewhat thrombocytopenic postoperatively, a heparin induced thrombocytopenia assay was sent which was negative. he tolerated advancement of his diet without abdominal pain or increase in his amylase or lipase. beta blockade was titrated for optimal heart rate and blood pressure control. mr. continued to make steady progress and was discharged home on postoperative day four. he will follow-up with dr. , his cardiologist and his primary care physician as an outpatient. medications on admission: lipitor 10mg daily atenolol 50mg daily prn discharge medications: 1. furosemide 20 mg tablet sig: one (1) tablet po q12h (every 12 hours) for 7 days. disp:*14 tablet(s)* refills:*0* 2. potassium chloride 10 meq capsule, sustained release sig: two (2) capsule, sustained release po q12h (every 12 hours) for 7 days. disp:*28 capsule, sustained release(s)* refills:*0* 3. oxycodone-acetaminophen 5-325 mg tablet sig: 1-2 tablets po q4h (every 4 hours) as needed for pain. disp:*50 tablet(s)* refills:*0* 4. atorvastatin calcium 10 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*2* 5. aspirin 81 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po daily (daily). disp:*30 tablet, delayed release (e.c.)(s)* refills:*2* 6. metoprolol tartrate 50 mg tablet sig: one (1) tablet po bid (2 times a day). disp:*60 tablet(s)* refills:*2* discharge disposition: home with service facility: hospice and vna discharge diagnosis: mitral regurgitation. discharge condition: good. discharge instructions: follow medications on discharge instructions. you may not drive for 4 weeks. you may not lift more than 10 lbs. for 4 weeks. you should shower, let water flow over wounds, pat dry with a towel. followup instructions: make an appointment with dr. for 1-2 weeks. make an appointment with dr. for 4 weeks. procedure: extracorporeal circulation auxiliary to open heart surgery diagnostic ultrasound of heart open and other replacement of mitral valve with tissue graft diagnoses: pure hypercholesterolemia mitral valve disorders personal history of other malignant neoplasm of skin acute pancreatitis 

Answer: The patient is high likely exposed to